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Aging is associated with a decline in cardiac function. Exercise intervention has
been suggested as a way to improve this decrement. Age-related decline in cardiac
function is associated with decreases in fatty acid oxidation, mitochondrial function,
and AMP-activated protein kinase (AMPK) activity. The molecular mechanisms involved
with age-related changes in mitochondrial function and substrate metabolism are poorly
understood. We determined gene expression differences in hearts of Young (6mo), Old
(33mo), and old exercise trained (Old+ EXE) (34mo) FBN rats, using Qiagen PCR arrays
for Glucose, Fatty acid, andMitochondrial metabolism. Old rats demonstrated decreased
(p < 0.05) expression for key genes in fatty acid oxidation, mitochondrial function, and
AMPK signaling. There were no differences in the expression of genes involved in glucose
metabolism with age. These gene expression changes occurred prior to altered protein
translation as we found no differences in the protein content of peroxisome proliferator
activated receptor gamma, coactivators 1 alpha (PGC-1α), peroxisome proliferator
activated receptor alpha (PPARα), and AMPKα2 between young and old hearts. Four
months of exercise training did not attenuate the decline in the gene expression in
aged hearts. Despite this lack of change in gene expression, exercise-trained rats
demonstrated increased exercise capacity compared to their sedentary counterparts.
Taken together, our results show that differential expression of genes associated with
fatty acid metabolism, AMPK signaling and mitochondrial function decrease in the aging
heart which may play a role in age-related declines in fatty acid oxidation, AMPK activity,
and mitochondrial function in the heart.
Keywords: mitochondrial biogenesis, gene expression, exercise training, fatty acid metabolism, glucose
metabolism
INTRODUCTION
Aging is associated with a decline in cardiac function in humans as well as rodents (Lakatta and
Sollott, 2002). The decline in cardiac function with age is associated with changes in mitochondrial
function and energy metabolism (Abu-Erreish et al., 1977; McMillin et al., 1993; Fannin et al.,
1999; Kates et al., 2003; Bhashyam et al., 2007; Chakravarti et al., 2008). Since the myocardium
derives nearly all of its energetic needs from the oxidation of pyruvate and fatty acids within the
mitochondria, mitochondrial changes have great potential to contribute to cardiac dysfunction with
age. Indeed, mitochondrial energetic deficiency with aging has been well-documented (McMillin
et al., 1993; Fannin et al., 1999; Phaneuf and Leeuwenburgh, 2002; Chakravarti et al., 2008; Ventura-
Clapier et al., 2008). The mechanisms of this mitochondrial dysfunction may include biogenesis
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that is inadequate to match the increasing demand (Goffart
et al., 2004), as well as increased mitochondrial uncoupling
and decreased substrate availability (Murray et al., 2004).
Several studies have documented age-dependent impairment in
the mitochondrial respiratory capacity (Kumaran et al., 2005;
Navarro and Boveris, 2007).
Concomitant with mitochondria functional changes there is a
change in cardiac substrate utilization during the aging process.
At rest, fatty acids are the primary substrate for ATP supply in
the myocardium and glucose uptake and oxidation supplies the
remainder of the carbon substrates (Wisneski et al., 1985). There
is some evidence that this substrate utilization changes with age
(Abu-Erreish et al., 1977; McMillin et al., 1993; Sample et al.,
2006), with most evidence indicating an age-related reduction in
fatty acid oxidation, with the implication of increased reliance on
glucose, although this is not universally seen (Sample et al., 2006).
Interestingly, it has been determined that glucose utilization itself
does not increase (Abu-Erreish et al., 1977; McMillin et al., 1993;
Kates et al., 2003).
The molecular mechanisms underlying age-related changes
in mitochondrial function or substrate energy metabolism is
largely unknown. Decreases in mRNA levels of peroxisome
proliferator-activated receptor (PPARα), and some of its
downstream targets (i.e., CPT-1, β-hydroxyacyl dehydrogenase)
have been observed with age (Iemitsu et al., 2002). In addition,
peroxisome proliferator activated receptor γ coactivator-1α
(PGC-1α) protein content is reduced in the aging left ventricle
(Turdi et al., 2010). PPARα is a transcription factor for genes
involved with fatty acid transport and β-oxidation (Huss and
Kelly, 2004). PGC-1α, a co-transcription factor is known to
stimulate mitochondrial DNA replication and the coding for
genes involved with oxidative phosphorylation (Huss and Kelly,
2004). Another mechanism for age-related changes in substrate
metabolism may be related to AMP-activated protein kinase
(AMPK) activity. Dually activated by AMP and by upstream
phosphorylation, this kinase promotes fatty acid oxidation,
glucose uptake, and glycogenolysis while it inhibits anabolic
processes such as fatty acid synthesis (Munday et al., 1988; Coven
et al., 2003; Hawley et al., 2003, 2005; Scott et al., 2004). There is
evidence that AMPK activity declines with age (Gonzalez et al.,
2004; Turdi et al., 2010). Changes in the expression, protein
content, or activity of PPARα, PGC-1α, and AMPK can help
explain some of the known changes in substrate metabolism
and mitochondrial function with age. However, these processes
are the result of complex pathways that require the coordinated
expression and function of a large number of genes and proteins,
but there are few studies that have examined the effects of
aging on the expression of the comprehensive array of genes
that are associated with substrate metabolism and mitochondrial
function.
Exercise training is known to improve indices of cardiac
function in humans (Fortney et al., 1992; Seals et al., 1994)
and rodents (Spurgeon et al., 1983; Iemitsu et al., 2002).
Specifically, these functional improvements include, increased
contractile function (Spurgeon et al., 1983; Fortney et al., 1992;
Seals et al., 1994; Iemitsu et al., 2002) and increased maximal
oxygen uptake (VO2max) (Ogawa et al., 1992; Seals et al., 1994;
Stratton et al., 1994). There is some evidence that exercise can
alter themetabolic phenotype of the aging heart. Exercise training
in agingWistar rats increased AMPK activity, PPARαmRNA and
protein content, and proteins involved in fatty acid oxidation
in the young and aged heart (Iemitsu et al., 2002; Rimbaud
et al., 2009; Dobrzyn et al., 2013). Also, lifelong voluntary
wheel running in mice increased electron transport chain (ETC)
complex IV gene expression (Bronikowski et al., 2003). There is
molecular evidence that exercise training can increase the mRNA
and protein levels of important proteins involved with fatty acid
oxidation and oxidative phosphorylation, these markers suggest
that these metabolic pathways may be improved with exercise
training (Iemitsu et al., 2002; Bronikowski et al., 2003; Rimbaud
et al., 2009; Dobrzyn et al., 2013). However, substrate metabolism
and mitochondrial oxidative phosphorylation in the heart are
regulated by the transcription, translation, and activity of many
genes in order to optimally function.
Therefore, the aims of this study was to: (1) determine the
effects of age on the expression of a large number of genes
related to the pathways of glucose and fatty acid metabolism,
and mitochondrial function; and (2) determine whether exercise
training could mitigate age-related changes in the expression
of metabolic and mitochondrial genes in the aging rat heart.
We hypothesize that expression of genes associated with the
pathways of fatty acid metabolism, AMPK signaling, and
mitochondrial function will decrease with age and that the
addition of exercise training in these aged rats will mitigate this
decrease in gene expression.
MATERIALS AND METHODS
Animals
Male Fischer 344 x Brown Norway hybrid rats (FBN), were
obtained from the National Institute on Aging colony at Harlan
Industries (Indianapolis, IN). The FBN hybrid rat is a long-lived
strain with a median life-span of 33 months and a maximum life-
span of 40 months. The FBN rat is considered a “healthy aging
model” widely used and highly recommended for gerontological
research. All rats were confined to standard size rodent cages
and housed 2 rats per cage. Rats had access to food and
water ad libitum and were acclimated to reverse daylight (12 h
dark, 12 h light). Body weights and average food intake were
monitored through the course of the study. Rats were randomly
assigned to one of three groups: Young (6 month), Old (33–34
month), and Old+ Exercise (Old+EXE) (33–34 month). Animal
housing and handling was carried out under the guidelines of the
University of Wisconsin-Madison Institutional Animal Care and
Use Committees and conducted in pathogen-free facilities that
are accredited by the American Association of Accreditation of
Laboratory Animal Care.
Tissue Collection
Old and Old + EXE hearts were removed and flash frozen
in liquid nitrogen 72 h from the last maximal exercise test in
order to control for transient gene expression changes due to
acute exercise (Neufer and Dohm, 1993; Pilegaard et al., 2000).
From the Old (n = 9) and Old + EXE (n = 9) rats, 5 hearts
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were randomly selected for qRT-PCR, Western blot, and citrate
synthase experiments, while Young (n = 5) hearts were used for
molecular analysis.
Maximal Exercise Testing
Assessment of peak exercise capacity occurred each month
beginning at 30 months until 34 months of age. The exercise
test started with a treadmill speed at 5m/min and progressively
increased by 3 m/min at each exercise stage. Animals ran at each
new treadmill speed for 3 min to assure steady-state values. To
encourage the rats to run, the treadmill was equipped with an
electric shock grid at the rear of the treadmill. The shock grid
was set to deliver a 0.2mA current, which gives an uncomfortable
shock but does not physically harm or injure the rat. The test
was terminated when animals were no longer able to maintain
position on the treadmill, and the highest speed was recorded
as peak exercise capacity. Blood lactate levels were measured
during the graded exercise tests. Blood lactate levels were used
to quantify relative exercise intensity. At the end of each 3
min interval, animals were briefly removed from the treadmill,
immobilized with the tail extended, the lateral tail vein pierced,
and a drop (∼25 µL) of blood was collected on a lactate
strip inserted into a lactate meter (Lactate Plus Meter, Nova
Biomedical). Blood lactate values were recorded at each exercise
intensity level during the exercise test.
Training Protocol
Trained animals were exercised on a motor driven treadmill
during their 12 h dark cycle. Before training began, animals were
treadmill acclimatized for 2 weeks at 5m/min for 5 min during
the first week and at 5 m/min for 10 min the second week.
After acclimatization, maximal exercise tests were performed and
blood lactate measurements were taken at each successive speed
on the treadmill during the test. The endurance trained rats began
exercise training at 30 months of age with a training program
that following 2 weeks of treadmill acclimation consisted of 30
min/day, 5 days per week at a speed that corresponded to each
animal’s lactate threshold. Thus, the training speed was adjusted
each month based on the results of the maximal exercise tests
(above). All exercise training sessions included a 3 min warm-
up period at 5 m/min. No negative stimuli (electric shock) were
used during the daily exercise training of the animals to minimize
stress involved in exercise for these aging animals.
RNA Isolation and cDNA Preparation
Rats were terminated using isoflurane/pneumothorax euthanasia
and hearts were removed and flash frozen in liquid nitrogen.
Total RNA from each rat was isolated from the left ventricular
free wall using RNeasy R© Microarray Tissue Mini Kit (Qiagen)
according to the manufacturer instruction. Immediately
after elution RNA concentration and purity was measured
spectrophotometrically (Beckman-Coulter). For each sample
700 ng of total RNA was reversed transcribed using the RT2 First
Strand Kit (Qiagen). The reaction was performed at 42◦C for 15
min followed by a termination step at 95◦C for 5min. cDNA was
stored at−20◦C until qRT-PCR.
qRT-PCR Data Analysis
A total of 251 genes of interest across three PCR arrays from
Qiagen were assayed for this study (Glucose Metabolism RT2
Profiler PCR Array, Fatty Acid Metabolism RT2 Profiler PCR
Array and RT2 Custom PCR Array for mitochondrial function).
A list of all of the genes contained in each array can be found
in Tables 1–3. PCR was performed on Step-One Plus PCR
system (Applied Biosystems), according to the manufacturer’s
instructions. For data analysis, the 11Ct method was used with
the aid of a Microsoft Excel spreadsheet containing algorithms
and a student’s t-test was used to analyze differences in fold-
changes in gene expression provided by the manufacturer
(Hassmann-Poznan´ska et al., 2013; Wu et al., 2013; Okada et al.,
2014). The 11Ct method for calculating differences in gene
expression are as follows: (1Ct = CtGOI − CtAVG HKG, where
GOI is the gene of interest and HKG is the housekeeping gene
selected.11Ct= (1Ct (Experimental group)−1Ct (Control)).
The housekeeping gene selected for data analysis was Ribosomal
protein, large P1 (Rplp1). Fold-changes were then calculated and
expressed as log-normalized ratios of values from Old/Young,
Old+ EXE/Young and Old+ EXE/Old heart tissues.
Western Blotting
Whole cell lysate from isolated left ventricle was prepared
using CelLyticTM MT Cell Lysis Reagent and 1:100 dilution of
Protease Inhibitor Cocktail (Sigma, St. Louis, MO). The protein
concentration was determined using Bio-Rad Protein Assay
(BioRad, Hercules, CA). Thirty micrograms of whole cellular
protein per lane was separated by SDS-PAGE with a 4–12%
Bis-Tris CriterionTM XT gel (XT MOPS running buffer) and
blotted onto a nitrocellulose membrane. The membrane was
incubated with blocking buffer (5% non-fat dry milk/TBS/0.1%
Tween 20) at room temperature for 1 h. The membrane was then
probed with the primary antibodies diluted in blocking buffer
overnight at 4◦C. Subsequently, membranes were incubated with
horseradish peroxidase-conjugated anti-rabbit antibody diluted
1:2000 in blocking buffer. Blots were developed with ClarityTM
Western ECL substrate (BioRad, Hercules, CA) and imaged
with GE ImageQuant LAS-4000 (GE Healthcare Bio-Sciences,
Pittsburgh, PA). The image of the blots was uploaded and
densitometry analysis was done with Image Studio Lite (LI-
COR Biosciences, Lincoln, NE). Protein content was measured
from the densitometry units from PGC-1α, AMPKα2,PPARα,
and normalized to vinculin.
Antibodies
Rabbit anti-PGC-1α, AMPKα2, and Vinculin antibodies were
acquired from Cell Signaling Technology, Inc., Beverly, MA.
Rabbit anti-PPARα antibody was purchased from Santa Cruz
Biotechnology, Inc., Santa Cruz, CA.
Citrate Synthase Activity
Maximal citrate synthase (CS) activity was determined in
left ventricular homogenates using (Citrate Synthase Assay
Kit, Sigma-Aldrich, St Louis, MO, USA) according to the
manufacturer’s protocol with absorbance kinetically measured at
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TABLE 1 | Gene list Glucose metabolism array.
Symbol Description
Acly ATP citrate lyase
Aco1 Aconitase 1, soluble
Aco2 Aconitase 2, mitochondrial
Agl Amylo-1,6-glucosidase, 4-alpha-glucanotransferase
Aldoa Aldolase A, fructose-bisphosphate
Aldob Aldolase B, fructose-bisphosphate
Aldoc Aldolase C, fructose-bisphosphate
Bpgm 2,3-bisphosphoglycerate mutase
Cs Citrate synthase
Dlat Dihydrolipoamide S-acetyltransferase
Dld Dihydrolipoamide dehydrogenase
Dlst Dihydrolipoamide S-succinyltransferase (E2 component of
2-oxo-glutarate complex)
Eno1 Enolase 1, (alpha)
Eno2 Enolase 2, gamma, neuronal
Eno3 Enolase 3, beta, muscle
Fbp1 Fructose-1,6-bisphosphatase 1
Fbp2 Fructose-1,6-bisphosphatase 2
Fh Fumarate hydratase 1
G6pc Glucose-6-phosphatase, catalytic subunit
G6pc3 Glucose 6 phosphatase, catalytic, 3
G6pd Glucose-6-phosphate dehydrogenase
Galm Galactose mutarotase (aldose 1-epimerase)
Gapdh Glyceraldehyde-3-phosphate dehydrogenase
Gapdhs Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
Gck Glucokinase
Gpi Glucose phosphate isomerase
Gsk3a Glycogen synthase kinase 3 alpha
Gsk3b Glycogen synthase kinase 3 beta
Gys1 Glycogen synthase 1, muscle
Gys2 Glycogen synthase 2
H6pd Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
Hk2 Hexokinase 2
Hk3 Hexokinase 3 (white cell)
Idh1 Isocitrate dehydrogenase 1 (NADP+), soluble
Idh2 Isocitrate dehydrogenase 2 (NADP+), mitochondrial
Idh3a Isocitrate dehydrogenase 3 (NAD+) alpha
Idh3b Isocitrate dehydrogenase 3 (NAD+) beta
Idh3g Isocitrate dehydrogenase 3 (NAD), gamma
Mdh1 Malate dehydrogenase 1, NAD (soluble)
Mdh1b Malate dehydrogenase 1B, NAD (soluble)
Mdh2 Malate dehydrogenase 2, NAD (mitochondrial)
Ogdhl Oxoglutarate dehydrogenase-like
Pc Pyruvate carboxylase
Pck1 Phosphoenolpyruvate carboxykinase 1 (soluble)
Pck2 Phosphoenolpyruvate carboxykinase 2 (mitochondrial)
Pdha2 Pyruvate dehydrogenase (lipoamide) alpha 2
Pdhb Pyruvate dehydrogenase (lipoamide) beta
Pdhx Pyruvate dehydrogenase complex, component X
Pdk1 Pyruvate dehydrogenase kinase, isozyme 1
Pdk2 Pyruvate dehydrogenase kinase, isozyme 2
Pdk3 Pyruvate dehydrogenase kinase, isozyme 3
Pdk4 Pyruvate dehydrogenase kinase, isozyme 4
(Continued)
TABLE 1 | Continued
Symbol Description
Pdp2 Pyruvate dehyrogenase phosphatase catalytic subunit 2
Pdpr Pyruvate dehydrogenase phosphatase regulatory subunit
Pfkl Phosphofructokinase, liver
Pgam2 Phosphoglycerate mutase 2 (muscle)
Pgk1 Phosphoglycerate kinase 1
Pgk2 Phosphoglycerate kinase 2
Pgls 6-phosphogluconolactonase
Pgm1 Phosphoglucomutase 1
Pgm2 Phosphoglucomutase 2
Pgm3 Phosphoglucomutase 3
Phka1 Phosphorylase kinase, alpha 1
Phkb Phosphorylase kinase, beta
Phkg1 Phosphorylase kinase, gamma 1
Phkg2 Phosphorylase kinase, gamma 2 (testis)
Pklr Pyruvate kinase, liver, and RBC
Prps1 Phosphoribosyl pyrophosphate synthetase 1
Prps1l1 Phosphoribosyl pyrophosphate synthetase 1-like 1
Pygl Phosphorylase, glycogen, liver
Pygm Phosphorylase, glycogen, muscle
Rbks Ribokinase
Rpia Ribose 5-phosphate isomerase A
Sdha Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
Sdhb Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
Sdhc Succinate dehydrogenase complex, subunit C, integral membrane
protein
Sdhd Succinate dehydrogenase complex, subunit D, integral membrane
protein
Sucla2 Succinate-CoA ligase, ADP-forming, beta subunit
Suclg1 Succinate-CoA ligase, alpha subunit
Suclg2 Succinate-CoA ligase, GDP-forming, beta subunit
Taldo1 Transaldolase 1
Tkt Transketolase
Tpi1 Triosephosphate isomerase 1
Ugp2 UDP-glucose pyrophosphorylase 2
412 nm at baseline and after addition of oxaloacetate (Sigma-
Aldrich). CS activity was normalized to protein content with
tissue protein determined using the Bio-Rad protein assay.
Statistical Analysis
A two-tailed Student’s t-test was used for analyzing differences in
gene expression and exercise performance. A one-way ANOVA
was utilized to analyze differences in protein content and citrate
synthase activity. Post-hoc analysis was performed when the one-
way ANOVAwas significant using Tukey’s LSD to assess between
group differences. Significance was determined at p< 0.05.
RESULTS
Effects of Exercise Training on Exercise
Performance
The effect of 4 months of exercise training on exercise
performance in 34 month old trained (Old + EXE) FBN
rats compared to sedentary (Old SED) rats was significant
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TABLE 2 | Gene list for Fatty Acid metabolism array.
Symbol Description
Acaa1a Acetyl-Coenzyme A acyltransferase 1A
Acaa2 Acetyl-Coenzyme A acyltransferase 2
Acad10 Acyl-Coenzyme A dehydrogenase family, member 10
Acad11 Acyl-Coenzyme A dehydrogenase family, member 11
Acad9 Acyl-Coenzyme A dehydrogenase family, member 9
Acadl Acyl-Coenzyme A dehydrogenase, long-chain
Acadm Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain
Acads Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain
Acadsb Acyl-Coenzyme A dehydrogenase, short/branched chain
Acadvl Acyl-Coenzyme A dehydrogenase, very long chain
Acat1 Acetyl-coenzyme A acetyltransferase 1
Acat2 Acetyl-Coenzyme A acetyltransferase 3
Acot12 Acyl-CoA thioesterase 12
Acot2 Acyl-CoA thioesterase 2
Acot3 Acyl-CoA thioesterase 3
Acot7 Acyl-CoA thioesterase 7
Acot8 Acyl-CoA thioesterase 8
Acot9 Acyl-CoA thioesterase 9
Acox1 Acyl-Coenzyme A oxidase 1, palmitoyl
Acox2 Acyl-Coenzyme A oxidase 2, branched chain
Acox3 Acyl-Coenzyme A oxidase 3, pristanoyl
Acsbg1 Acyl-CoA synthetase bubblegum family member 1
Acsbg2 Acyl-CoA synthetase bubblegum family member 2
Acsl1 Acyl-CoA synthetase long-chain family member 1
Acsl3 Acyl-CoA synthetase long-chain family member 3
Acsl4 Acyl-CoA synthetase long-chain family member 4
Acsl5 Acyl-CoA synthetase long-chain family member 5
Acsl6 Acyl-CoA synthetase long-chain family member 6
Acsm2a Acyl-CoA synthetase medium-chain family member 2
Acsm3 Acyl-CoA synthetase medium-chain family member 3
Acsm4 Acyl-CoA synthetase medium-chain family member 4
Acsm5 Acyl-CoA synthetase medium-chain family member 5
Aldh2 Aldehyde dehydrogenase 2 family (mitochondrial)
Bdh1 3-hydroxybutyrate dehydrogenase, type 1
Bdh2 3-hydroxybutyrate dehydrogenase, type 2
Cpt1a Carnitine palmitoyltransferase 1a, liver
Cpt1b Carnitine palmitoyltransferase 1b, muscle
Cpt1c Carnitine palmitoyltransferase 1c
Cpt2 Carnitine palmitoyltransferase 2
Crat Carnitine acetyltransferase
Crot Carnitine O-octanoyltransferase
Decr1 2,4-dienoyl CoA reductase 1, mitochondrial
Decr2 2,4-dienoyl CoA reductase 2, peroxisomal
Echs1 Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
Eci2 Enoyl-Coenzyme A delta isomerase 2
Ehhadh Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A
dehydrogenase
Fabp1 Fatty acid binding protein 1, liver
Fabp2 Fatty acid binding protein 2, intestinal
Fabp3 Fatty acid binding protein 3, muscle, and heart
Fabp4 Fatty acid binding protein 4, adipocyte
(Continued)
TABLE 2 | Continued
Symbol Description
Fabp5 Fatty acid binding protein 5, epidermal
Fabp6 Fatty acid binding protein 6, ileal
Fabp7 Fatty acid binding protein 7, brain
Gcdh Glutaryl-Coenzyme A dehydrogenase
Gk Glycerol kinase
Gk2 Glycerol kinase 2
Gpd1 Glycerol-3-phosphate dehydrogenase 1 (soluble)
Gpd2 Glycerol-3-phosphate dehydrogenase 2, mitochondrial
Hadha Hydroxyacyl-Coenzyme A dehydrogenasea
Hmgcl 3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase
Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)
Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2
(mitochondrial)
Lipe Lipase, hormone sensitive
Lpl Lipoprotein lipase
Mcee Methylmalonyl CoA epimerase
Mut Methylmalonyl-Coenzyme A mutase
Oxct2a 3-oxoacid CoA transferase 2A
Pecr Peroxisomal trans-2-enoyl-CoA reductase
Ppa1 Pyrophosphatase (inorganic) 1
Prkaa1 Protein kinase, AMP-activated, alpha 1 catalytic subunit
Prkaa2 Protein kinase, AMP-activated, alpha 2 catalytic subunit
Prkab1 Protein kinase, AMP-activated, beta 1 non-catalytic subunit
Prkab2 Protein kinase, AMP-activated, beta 2 non-catalytic subunit
Prkaca Protein kinase, cAMP-dependent, catalytic, alpha
Prkacb Protein kinase, cAMP dependent, catalytic, beta
Prkag1 Protein kinase, AMP-activated, gamma 1 non-catalytic subunit
Prkag2 Protein kinase, AMP-activated, gamma 2 non-catalytic subunit
Prkag3 Protein kinase, AMP-activated, gamma 3 non-catalytic subunit
Slc27a1 Solute carrier family 27 (fatty acid transporter), member 1
Slc27a2 Solute carrier family 27 (fatty acid transporter), member 2
Slc27a3 Solute carrier family 27 (fatty acid transporter), member 3
Slc27a4 Solute carrier family 27 (fatty acid transporter), member 4
Slc27a5 Solute carrier family 27 (fatty acid transporter), member 5
Slc27a6 Solute carrier family 27 (fatty acid transporter), member 6
aHydroxyacyl-Coenzyme A dehydrogenase 3-ketoacyl-Coenzyme A thiolase/enoyl-
Coenzyme A hydratase (trifunctional protein), alpha subunit.
(Figure 1). We measured exercise capacity in two different ways;
(1) treadmill speed at lactate threshold (LT) and (2) peak exercise
capacity (the final treadmill speed achieved during the maximal
exercise test). Exercise training significantly improved lactate
threshold (p < 0.01) in the Old + EXE rats compared to Old
SED rats (Figure 1A). Peak exercise capacity was also greater
(p = 0.01) in the Old + EXE rats compared to Old SED rats
(Figure 1B).
Gene Expression Changes with Age
To determine the effects of age on the expression of genes
involved in cardiac glucose and fatty acid metabolism as well
as mitochondrial function we performed qRT-PCR using three
different PCR arrays. Table 4 shows all genes in the energetic
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TABLE 3 | Gene list for the Custom array.
Symbol Description
Ppargc1 Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
Nrf1 Nuclear respiratory factor 1
Tfam Transcription factor A, mitochondrial
Sir2 Sirtuin (Silent mating type information regulation 2 homolog) 2
Esrra Estrogen related receptor, alpha
Prkaa2 Protein kinase, AMP-activated, alpha 2 catalytic subunit
CREB1 cAMP response element binding protein 1
CaMK4 Calcium/calmodulin-dependent protein kinase IV
SOD2 Superoxide dismutase 2, mitochondrial
UCP2 Uncoupling protein 2 (mitochondrial proton carrier)
UCP3 Uncoupling protein 3 (mitochondrial proton carrier)
Bax Bcl2–associated X protein
Bcl2 B-cell CLL/lymphoma 2
Casp3 Caspase 3
Gabpa GA binding protein transcription factor (alpha subunit) (i.e., NRF-2a)
UCP1 Uncoupling protein 1 (mitochondrial proton carrier)
Ppara Peroxisome proliferator activated receptor alpha
Slc2a4 Solute carrier family 2 (facilitated glucose transporter) member 4
CD36 CD 36 molecule (thrombospondin receptor)
Acacb Acetyl-Coenzyme A carboxylase beta
Mlycd Malonyl-CoA decarboxylase
Ndufa1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1
Ndufa10 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10
Ndufa11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11
Ndufa2 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2
Ndufa5 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5
Ndufa6 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6
Ndufa7 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7
Ndufa8 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8
Ndufa9 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9
Ndufab1 NADH dehydrogenase (ubiquinone) 1 alpha/beta subcomplex, 1
Ndufb2 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2
Ndufb3 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3
Ndufb5 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5
Ndufb6 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6
Ndufb7 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7
Ndufb8 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8
Ndufb9 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9
Ndufc2 NADH dehydrogenase (ubiquinone) 1 subcomplex unknown, 2
Ndufs1 NADH dehyrogenase (ubiquinone) Fe-S protein 1
Ndufs2 NADH dehyrogenase (ubiquinone) Fe-S protein 2
Ndufs3 NADH dehyrogenase (ubiquinone) Fe-S protein 3
Ndufs4 NADH dehyrogenase (ubiquinone) Fe-S protein 4
Ndufs6 NADH dehyrogenase (ubiquinone) Fe-S protein 6
Ndufs7 NADH dehyrogenase (ubiquinone) Fe-S protein 7
Ndufs8 NADH dehyrogenase (ubiquinone) Fe-S protein 8
Ndufv1 NADH dehydrogenase (ubiquinone) flavoprotein 1
Ndufv2 NADH dehyrogenase (ubiquinone) flavoprotein 2
Bcs1l BCS1-like yeast
Cyc1 Cytochrome c-1
Uqcrb Ubiquinol-cytochrome c reductase binding protein
(Continued)
TABLE 3 | Continued
Symbol Description
Uqcrc1 Ubiquinol-cytochrome c reductase core protein 1
Uqcrc2 Ubiquinol-cytochrome c reductase core protein 2
Uqcrfs1 Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
Uqcrh Ubiquinol-cytochrome c reductase hinge protein
Uqcrq Ubiquinol-cytochrome c reductase, complex III subunit VII
Cox15 COX 15 homolog, cytochrome c oxidase assembly protein (yeast)
Cox17 COX 17 cytochrome c oxidase assembly homolog (S. cerevisiae)
Cox4i1 Cytochrome c oxidase subunit IV isoform 1
Cox4i2 Cytochrome c oxidase subunit IV isoform 2
Cox5a Cytochrome c oxidase subunit Va
Cox5b Cytochrome c oxidase subunit Vb
Cox6a1 Cytochrome c oxidase subunit VIa polypeptide 1
Cox6a2 Cytochrome c oxidase subunit VIa polypeptide 2
Cox6c Cytochrome c oxidase subunit VIc
Cox7a2 Cytochrome c oxidase subunit VIIa polypeptide 2
Cox7a2l Cytochrome c oxidase subunit VIIa polypeptide 2 like
Cox7b Cytochrome c oxidase subunit VIIb polypeptide
Cox8a Cytochrome c oxidase subunit VIIIa
Cox8c Cytochrome c oxidase subunit VIIIc
mfn1 Mitofusin 1
mfn2 Mitofusin 2
fis1 Fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
lonp1 Lon protease
Aifm2 Apoptosis-inducing factor, mitochondrial-associated 2
Bcl2l1 Bcl2-like 1
Clpb ClpB caseinolytic peptidase B homolog (E. coli) (i.e. HSP 78)
pnpt1 Polyribonucleotide nucleotidyltransferase 1
Me1 Malic enzyme 1, NADP(+)-dependent, cytosolic
Foxo3 Forkhead box O3
Camkk2 Calcium/calmodulin-dependent protein kinase kinase 2,beta
Stk11 Serine/threonine kinase 11 (i.e., LKB1)
Ppargc1b Peroxisome proliferator-activated receptor gamma, coactivator 1 beta
Tp53 Tumor protein p53
pathways for which expression was significantly different
between Old and Young rats. Between the three arrays there
were a total of 44 genes that were differentially expressed (p <
0.05) in Old compared to Young. Of the 44 genes differentially
expressed, 42 of these genes had decreased expression in Old
compared to Young. Notably, the expression profile of three
important pathways of energy production were altered with
age; fatty acid oxidation (FAO), mitochondrial biogenesis, and
AMPK signaling. There were no significant changes in glucose
metabolism gene expression with age. Figure 2 shows changes
in expression with age in key genes involved in the pathways of
FAO, mitochondrial biogenesis, and AMPK signaling.
Effects of Exercise Training on Gene
Expression in Aged Hearts
Differences in gene expression were observed between Old
and Old + EXE rat hearts (Table 5). 70 genes associated
with glucose metabolism, FA metabolism and mitochondrial
function were altered with exercise training in cardiac tissue of
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FIGURE 1 | Effects of exercise training on peak exercise capacity in 34
month old FBN rats. Values are the Means ± S.E.M of treadmill speed and
peak exercise capacity of trained and sedentary rats. (A) We measured
exercise capacity as a function of treadmill speed at lactate threshold (LT) (B)
Peak exercise capacity was measured as the maximal speed at the end of the
maximal exercise testing. Old SED (n = 9), Old + EXE (n = 9). *P < 0.05.
old rats compared to that of old sedentary rats. Of these 70
genes, only three were upregulated (Prkaa1, Slc27a1, Slc27a4),
while 67 genes were downregulated with exercise training and
involved genes from the Kreb’s cycle, glucose transport (Glut4),
fatty acid oxidation, and the mitochondrial electron transport
chain.
Western Blot Analysis
In order to determine if the gene expression changes with age and
exercise training were associated with altered protein content, we
selected one protein from fatty acid oxidation (PPARα), AMPK
signaling (AMPKα2), and mitochondrial biogenesis/function
(PGC-1α) categories shown in Figure 2. Each of these genes
had decreased mRNA expression and decreased protein content
between Young and Old, although not significantly for PPARα
(Figure 3). PGC-1α and AMPKα2 protein content was decreased
in the Old + EXE compared to Young and not different than
Old, but PPARα protein content was greater in the Old + EXE
rat hearts compared to Old rat hearts.
Citrate Synthase Activity
To determine mitochondrial function and volume we assayed
citrate synthase activity in left ventricular homogenates.
We found that Old rat hearts had increased citrate
synthase activity compared to Young hearts, and the
Old + EXE hearts demonstrated no differences in citrate
synthase activity compared to Young or Old hearts
(Figure 4).
DISCUSSION
To our knowledge this is the first study to determine the effects of
age on the expression of a comprehensive group of genes related
to cardiac substrate metabolism and mitochondrial function.
The other primary aim of this study was to determine whether
exercise training in aged rats could alter the age-related gene
expression phenotype. We hypothesized that genes associated
with fatty acid oxidation, AMPK signaling, and mitochondrial
biogenesis/function would be decreased with age and that
exercise training would mitigate these changes in aged rat hearts.
We found that aging results in the decreased expression of
many genes involved with energy metabolism and mitochondrial
function but found that exercise training did not improve the
downregulation of these genes. In fact, exercise training in
aged rats resulted in the downregulation of 67 genes associated
with energy metabolism and mitochondrial function compared
to aged sedentary rat hearts. Genes associated with glucose
metabolism were unaffected by age. The declines in metabolic
gene expression were profound, as we observed decreased
expression in 42 genes involved with fatty acid metabolism and
mitochondrial function in aged hearts compared to young hearts.
In aged sedentary hearts altered protein content of PGC-1α and
AMPKα2 corresponded to declines in gene expression compared
to young hearts.We observed that cardiacmuscle citrate synthase
activity; a common measure of mitochondrial volume in skeletal
muscle (Larsen et al., 2012) was increased in the aged heart
compared to the young heart, while exercise training in aged
hearts showed no differences between young and old sedentary
rat hearts. Overall, these results suggest a significant change in the
expression of genes associated with cardiac metabolic pathways
with age that is not improved with exercise training.
We determined that a large number of genes involved
with fatty acid metabolism and mitochondrial energy
metabolism/biogenesis were downregulated with age, consistent
with previous reports suggesting age-related reductions in fatty
acid oxidation (Abu-Erreish et al., 1977; McMillin et al., 1993;
Kates et al., 2003), AMPK activity (Gonzalez et al., 2004; Turdi
et al., 2010; Zhao et al., 2014), and mitochondrial function
(Fannin et al., 1999; Wanagat et al., 2002; Kumaran et al., 2005;
Bhashyam et al., 2007; Preston et al., 2008; Jian et al., 2011).
Specifically, we found genes associated with FAO (i.e., CPT-2,
HADHA), AMPK signaling (i.e., AMPKα2, CaMKK2, LKB1),
and mitochondrial biogenesis (PGC-1α, PGC-1β) with age-
related decrements in expression in the myocardium. Cardiac
PGC-1α expression has previously been shown to decline with
age (Preston et al., 2008; Turdi et al., 2010), although others
have observed no age-related change in cardiac PGC-1α gene
expression (LeMoine et al., 2006). Our results demonstrated
that the genes associated with fatty acid oxidation that were
downregulated with age were primarily PPARα regulated
transcripts. As in previous studies, we found that expression of
FAO genes downstream of PPARα were decreased (Iemitsu et al.,
2002; LeMoine et al., 2006). However, our finding of a decline
in PPARα regulated genes associated with FAO in aged hearts
occurred despite no change in expression of the PPARα gene
itself between young and old hearts. Although, this decline in
Frontiers in Physiology | www.frontiersin.org 7 August 2016 | Volume 7 | Article 352
Barton et al. Gene Expression Changes Aged Heart
TABLE 4 | Age-related gene expression changes in the left ventricle.
Gene name Gene symbol Fold Regulation p-value
FA METABOLISM
Acyl-CoA thioesterase 12 Acot12 2.88 0.026
Acyl-CoA thioesterase 7 Acot7 −1.86 0.017
Acyl-CoA thioesterase 8 Acot8 −1.44 0.02
Acyl-Coenzyme A oxidase 1, palmitoyl Acox1 −2.1 0.032
Acyl-CoA synthetase bubblegum family member 1 Acsbg1 2.09 0.034
Acyl-CoA synthetase long-chain family member 6 Acsl6 −1.98 0.029
3-hydroxybutyrate dehydrogenase, type 1 Bdh1 −2.55 0.036
Carnitine palmitoyltransferase 1c Cpt1c −1.49 0.027
Carnitine palmitoyltransferase 2 Cpt2 −2.02 0.001
Carnitine acetyltransferase Crat −2.69 0.011
2,4-dienoyl CoA reductase 1, mitochondrial Decr1 −2.05 0.03
Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial Echs1 −2.39 0.004
Enoyl-Coenzyme A delta isomerase 2 Eci2 −1.79 0.049
Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase Ehhadh −3.29 0.034
Fatty acid binding protein 3, muscle and heart Fabp3 −2.84 0.017
Glutaryl-Coenzyme A dehydrogenase Gcdh −1.97 0.013
Glycerol-3-phosphate dehydrogenase 2, mitochondrial Gpd2 −2.64 0.028
Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme
A hydratase (trifunctional protein), alpha subunit
Hadha −2.23 0.035
3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase Hmgcl −1.51 0.03
Lipase, hormone sensitive Lipe −2.14 0.03
Lipoprotein lipase Lpl −2.31 0.025
Peroxisomal trans-2-enoyl-CoA reductase Pecr −1.67 0.013
Pyrophosphatase (inorganic) 1 Ppa1 −1.78 0.03
Protein kinase, AMP-activated, alpha 2 catalytic subunit Prkaa2 −2.09 0.034
Protein kinase, AMP-activated, beta 1 non-catalytic subunit Prkab1 −3.96 0.041
Protein kinase, AMP-activated, beta 2 non-catalytic subunit Prkab2 −1.7 0.041
Protein kinase, cAMP-dependent, catalytic, alpha Prkaca −2.03 0.005
Protein kinase, cAMP dependent, catalytic, beta Prkacb −1.65 0.031
Protein kinase, AMP-activated, gamma 1 non-catalytic subunit Prkag1 −1.77 0.002
Solute carrier family 27 (fatty acid transporter), member 1 Slc27a1 −2.02 0.03
MITOCHONDRIAL FUNCTION
Peroxisome proliferator—activated receptor gamma, coactivator 1 alpha Ppargc1 −2.14 0.03
NADH dehydrogenase (ubiquinone) Fe-S protein 7 Ndufs7 −2.24 0.015
Ubiquinol - cytochrome c reductase, complex III subunit VII Uqcrq −1.48 0.05
COX17 cytochrome c oxidase assembly homolog (S. cerevisiae) Cox17 −1.68 0.011
Cytochrome c oxidase subunit IV isoform 1 Cox4i1 −1.72 0.02
Cytochrome c oxidase subunit VIIa polypeptide 2 like Cox7a2l −1.35 0.049
Mitofusin 1 mfn1 −2.41 0.01
Mitofusin 2 mfn2 −3.21 0.028
Clpb caseinolytic peptidase B homolog (E. coli) (i.e. HSP78) clpb −2.3 0.039
Calcium/calmodulin-dependent protein kinase kinase 2, beta Camkk2 −1.77 0.017
Serine/threonine kinase 11 (i.e. LKB1) Stk11 −1.86 0.029
Peroxisome proliferator - activated receptor gamma, coactivator 1 beta Ppargc1b −2.69 0.012
Tumor protein p53 Tp53 −2.19 0.025
genes associated with FAO is likely explained by reduced PPARα
protein content in old hearts compared to young. This finding
suggests that in the aged heart, changes in PPARα is likely to
occur downstream of gene expression. Lastly, we demonstrated
that the gene expression of AMPKα2 decreased with age, which
is the major catalytic subunit in the heart and responsible
for the phosphorylation of downstream proteins that confer
AMPK’s effect on energy metabolism in the heart (Dolinsky
and Dyck, 2006). Also, we found decreased gene expression
in the aging heart of two protein kinases (CaMKK2 & LKB1)
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FIGURE 2 | Fold changes in gene expression Old and Old + EXE hearts
relative to young hearts (Values are the Means ± S.E.M, n = 5 per
group). (A) Genes involved in fatty acid transport and oxidation decline with
age and this attenuation is not mitigated with exercise. (CPT1c,
Carnitine-palmitoyl transferase 1c; CPT2, Carnitine palmitoyl transferase 2;
FATP, Fatty acid transporter; FABP3, Fatty acid binding protein 3; HADHA,
Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A
thiolase/enoyl-CoA hydratase (trifunctional protein); LPL, Lipoprotein lipase).
(B) AMPK signaling decrements with age involve changes in the gene
expression of AMPK subunits and upstream kinases. (AMPKα2, Protein
kinase; AMP, activated alpha 2 catalytic subunit; AMPKβ1, Protein kinase;
AMP, activated beta 1 non-catalytic subunit; AMPKγ1, Protein kinase; AMP,
activated gamma 1 non-catalytic sununit; Camkk2,
Calcium/calmodulin-dependent protein kinase kinase 2 beta; LKB1, Liver
kinase B 1). (C) Mitochondrial biogenesis and maintenance of mitochondrial
function decline with age and exercise does not appear to improve the
attenuation. (PGC1α, Peroxisome proliferator—activated receptor gamma,
coactivator 1 alpha; PGC1β, Peroxisome proliferator—activator receptor
gamma, coactivator 1 beta; Mfn1, Mitofusin 1; Mfn2, Mitofusin 2; HSP78,
Heat shock protein 78). aP < 0.05 vs. Young, bP < 0.05 vs. Old + EXE.
that have been found to phosphorylate AMPK. These findings
suggest that declining transcripts of AMPK and two upstream
activators (CaMKK2 & LKB1), may play a role in the reduced
AMPK activity that has been previously observed in aged hearts
(Gonzalez et al., 2004; Turdi et al., 2010).
There is little information with regard to gene expression and
protein content changes in exercise-trained aged rat hearts with
regard to fatty acid oxidation, AMPK signaling, or mitochondrial
function, but functional studies led us to hypothesize that exercise
training would improve the age-related declines in metabolic
gene expression. Surprisingly, we found that exercise training did
not attenuate the age-related downregulation in the expression
of genes involving fatty acid oxidation, AMPK signaling, and
mitochondrial function. Specifically, in old exercise-trained
hearts compared to old hearts we found a significant decline in
the expression of the PPARα gene. PPARα regulated genes that
were downregulated by exercise were Acyl CoA dehydrogenases
(Acad), CD36, CPT1b, and CPT2. There were no differences in
AMPK signaling genes (Figure 2B) between Old + EXE and
Old rats; however, there was an upregulation of AMPKα1 in
the exercise trained rats. AMPKα1 is ubiquitously expressed
in cells and has lower levels of expression in the myocardium
compared to AMPKα2 (Dolinsky and Dyck, 2006). We also
found that compared to old rat hearts, exercise trained rat hearts
demonstrated further downregulation of many genes involved
with glucose transport (Glut4), Kreb’s cycle and mitochondrial
function (complex I and III in the electron transport chain). This
downregulation of genes we observed in exercise trained aged
hearts will require further work in order to better understand
how exercise training induced downregulation of these genes
affects cardiac function.
In order to determine if changes in gene expression with
age were associated with altered protein content we measured
the protein content of PGC-1α, PPARα, and AMPKα2. We
found that the protein levels of PGC-1α and AMPKα2 were
decreased in Old hearts compared to Young hearts and PPARα
protein content trended toward a significant decline which was
similar to the mRNA expression for these genes. In a previous
report, mitochondrial oxygen consumption and expression of
genes associated with mitogenesis and mitochondrial energy
metabolism were both decreased, but mitochondrial number was
increased and the mitochondrial marker, citrate synthase was not
different in the senescent hearts compared to young (Preston
et al., 2008). We observed a similar trend, of an increase in
citrate synthase activity in Old hearts compared to Young hearts
despite a decrease in gene expression of a large number of genes
associated with mitochondrial biogenesis.
Western blot analysis determined that in the old-exercise
trained rats PGC-1α and AMPKα2 protein content decreased
compared to young hearts, similar to our findings of decreased
gene expression of these two genes. However, we found that
PGC-1α mRNA expression was reduced in Old + EXE hearts
compared to Old hearts, yet the protein content of PGC-1α was
similar. Also, we found that the PPARα mRNA expression was
significantly reduced in Old + EXE hearts compared to Young
and Old hearts, yet PPARα protein content was significantly
greater in Old + EXE hearts compared to Old hearts and similar
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TABLE 5 | Exercise-related changes in gene expression in Old FBN rats.
Gene name Gene symbol Fold Regulation p-value
GLUCOSE METABOLISM
Amylo-1,6-glucosidase, 4-alpha-glucanotransferase Agl −6.15 0.024
Aldolase A, fructose-bisphosphate Aldoa −5.28 0.036
Enolase 1, (alpha) Eno1 −4.1 0.042
Enolase 2, gamma, neuronal Eno2 −3.27 0.019
Glucose phosphate isomerase Gpi −5.59 0.005
Glycogen synthase kinase 3 alpha Gsk3a −3.17 0.046
Isocitrate dehydrogenase 3 (NAD+) beta Idh3b −7.7 0.04
Isocitrate dehydrogenase 3 (NAD), gamma Idh3g −5.41 0.027
Malate dehydrogenase 2, NAD (mitochondrial) Mdh2 −6.31 0.009
Pyruvate dehydrogenase kinase, isozyme 1 Pdk1 −9.29 0.004
Pyruvate dehydrogenase kinase, isozyme 2 Pdk2 −6.48 0.006
Phosphoglucomutase 3 Pgm3 −1.7 0.037
Phosphorylase kinase, gamma 1 Phkg1 −2.78 0.011
Ribose 5-phosphate isomerase A Rpia −2.38 0.018
Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) Sdha −3.93 0.038
Succinate-CoA ligase, ADP-forming, beta subunit Sucla2 −5.64 0.021
Solute carrier family 2 (facilitated glucose transporter), member 4 Slc2a4 −10.45 0.025
FA METABOLISM
Acetyl-Coenzyme A acyltransferase 1A Acaa1a −9.79 0.001
Acetyl-Coenzyme A acyltransferase 2 Acaa2 −11.7 0.029
Acyl-Coenzyme A dehydrogenase family, member 10 Acad10 −7.02 0.002
Acyl-Coenzyme A dehydrogenase family, member 11 Acad11 −14.38 0.002
Acyl-Coenzyme A dehydrogenase family, member 9 Acad9 −8.81 0.008
Acyl-Coenzyme A dehydrogenase, long-chain Acadl −21.18 0.002
Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain Acadm −15.17 0.009
Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain Acads −17.09 0.001
Acyl-Coenzyme A dehydrogenase, short/branched chain Acadsb −7.75 0.007
Acyl-Coenzyme A dehydrogenase, very long chain Acadvl −9.49 0.002
Acetyl-coenzyme A acetyltransferase 1 Acat1 −14.79 0.004
Acetyl-Coenzyme A acetyltransferase 3 Acat2 −6.25 0.003
Acyl-CoA thioesterase 2 Acot2 −18.92 < 0.001
Acyl-CoA thioesterase 3 Acot3 −3.52 0.024
Acyl-CoA thioesterase 7 Acot7 −4.43 0.027
Acyl-CoA thioesterase 8 Acot8 −2.68 0.002
Acyl-CoA thioesterase 9 Acot9 −5.41 0.001
Acyl-Coenzyme A oxidase 1, palmitoyl Acox1 −5.16 0.007
Acyl-Coenzyme A oxidase 3, pristanoyl Acox3 −4.47 0.015
Acyl-CoA synthetase long-chain family member 1 Acsl1 −18.06 < 0.001
Acyl-CoA synthetase long-chain family member 3 Acsl3 −3.6 0.008
Acyl-CoA synthetase long-chain family member 4 Acsl4 −2.46 0.011
Acyl-CoA synthetase long-chain family member 5 Acsl5 −2.23 0.001
Acyl-CoA synthetase long-chain family member 6 Acsl6 −5.54 0.01
3-hydroxybutyrate dehydrogenase, type 1 Bdh1 −10.48 0.04
3-hydroxybutyrate dehydrogenase, type 2 Bdh2 −5.03 0.008
Carnitine palmitoyltransferase 1a, liver Cpt1a −3.04 0.033
Carnitine palmitoyltransferase 1b, muscle Cpt1b −7.93 0.003
Carnitine palmitoyltransferase 2 Cpt2 −7.02 0.004
Carnitine acetyltransferase Crat −4.27 0.018
Fatty acid binding protein 3, muscle and heart Fabp3 −7.31 0.034
Protein kinase, AMP-activated, alpha 1 catalytic subunit Prkaa1 1.83 0.042
(Continued)
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TABLE 5 | Continued
Gene name Gene symbol Fold Regulation p-value
Protein kinase, cAMP-dependent, catalytic, alpha Prkaca −2.89 0.041
Protein kinase, cAMP dependent, catalytic, beta Prkacb −1.43 0.047
Solute carrier family 27 (fatty acid transporter), member 1 Slc27a1 1.73 0.033
Solute carrier family 27 (fatty acid transporter), member 4 Slc27a4 3.15 0.002
CD36 molecule (thrombospondin receptor) CD36 −2.97 0.001
Peroxisome proliferator activated receptor alpha Ppara −9.28 0.029
MITOCHONDRIAL FUNCTION
Sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae) Sirt1 −3.27 0.036
NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 1 Ndufa1 −2.24 0.04
NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14) Ndufa6 −4.7 0.041
NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 7 Ndufa7 −5.67 0.033
NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 8 Ndufa8 −10.41 0.005
NADH dehyrogenase (ubiquinone) 1 alpha subcomplex, 9 Ndufa9 −5.71 0.018
NADH dehyrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 Ndufab1 −5.67 0.001
NADH dehyrogenase (ubiquinone) 1 beta subcomplex, 2 Ndufb2 −4.49 0.006
NADH dehyrogenase (ubiquinone) 1 beta subcomplex, 5 Ndufb5 −4.72 0.032
NADH dehyrogenase (ubiquinone) 1 beta subcomplex, 8 Ndufb8 −4.92 0.01
NADH dehyrogenase (ubiquinone) Fe-S protein 6 Ndufs6 −2.94 0.047
Cytochrome c-1 Cyc1 −5.47 0.033
Ubiquinol-cytochrome c reductase core protein 2 Uqcrc2 −5.38 0.016
Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 Uqcrfs1 −5.11 0.045
compared to Young hearts. These results are somewhat conflicted
to a report demonstrating that exercise training attenuated the
age-related decrement in PPARα mRNA expression and protein
content in aged rat myocardium (Iemitsu et al., 2002). This study
indicated that decreased mRNA expression did result in similar
declines in protein content. However, functional changes do
not always coincide with coordinate changes in gene expression
or protein content (Burelle et al., 2004; Zhu et al., 2013; Lai
et al., 2014). Changes in gene expression due to exercise training
in aged hearts may or may not coincide with changes in that
gene’s protein product. Specifically, one study demonstrated that
exercise training elicited adaptations that lead to an increase in
exercise capacity along with augmented glucose and fatty acid
oxidation in the myocardium despite no changes in the protein
content of several proteins involved with glucose and fatty acid
metabolism (Burelle et al., 2004). Our results demonstrated
despite many genes involved with FAO in the exercise trained
aged heart was reduced to aged sedentary hearts, PPARα protein
content was greater in exercise trained aged hearts compared
to aged sedentary hearts. Future studies looking at the protein
content of major proteins involved with β-oxidation and fatty
acid transport would enable us to see if exercise training in aged
hearts tends to uncouple gene expression from protein content.
Citrate synthase is a common marker of mitochondrial
volume used to indicate endurance exercise adaptations in
skeletal muscle (Larsen et al., 2012). We examined citrate
synthase activity in cardiac muscle and found, surprisingly, that
aging resulted in an increase in citrate synthase activity and
exercise training diminished this effect. Citrate synthase activity
was not different in old-exercise trained hearts compared to
young or old hearts. This is consistent with previous studies
demonstrating that exercise training in rats did not elicit
increases in cardiac citrate synthase activity (Oscai et al., 1971;
Murakami et al., 1995; Zonderland et al., 1999; Siu et al., 2003;
Rimbaud et al., 2009). We found that exercise training improved
functional exercise capacity (Figure 4) despite either no changes
in gene expression compared to Old hearts or in some cases,
a further reduction in the expression of genes associated with
energy metabolism and mitochondrial function in the heart.
These data suggest that exercise training may impact myocardial
energy metabolism and mitochondrial function downstream of
gene expression. Also, exercise is known to induce adaptations
in skeletal muscle (Hall et al., 1994; Bengtsson et al., 2001; Betik
et al., 2008; Kang et al., 2013), which may have been responsible
for the increased exercise capacity in our old exercise-trained rats.
LIMITATIONS
One limitation to this study is that we did not determine whether
exercise training in young rats leads to a similar downregulation
of the expression of these cardiac genes that we found in the
exercise trained aged hearts. Cardiac gene expression changes
due to exercise training in young rats have been well-studied.
These studies showed that mitochondrial or metabolic gene
expression in the young rat heart to either increase (Hall et al.,
1994; Rimbaud et al., 2009; Dobrzyn et al., 2013; Wadley et al.,
2016) or not change (Murakami et al., 1995; Iemitsu et al., 2003;
Alessio et al., 2014) with exercise training compared to young
sedentary rats. Specifically, young hearts respond to exercise
training by increasing the expression of genes associated with
Frontiers in Physiology | www.frontiersin.org 11 August 2016 | Volume 7 | Article 352
Barton et al. Gene Expression Changes Aged Heart
FIGURE 3 | Relative protein content in Young, Old, and Old + EXE groups (n = 5 per group). Values represent Means ± S.E.M. Old + EXE demonstrate
increases in PGC-1α but decreased PPARα and AMPKα2 protein content compared to Young and Old, respectively. *P < 0.05 vs. Young,
†
P < 0.05 vs. Old + EXE.
FIGURE 4 | Citrate synthase activity in left ventricular homogenates in
young, old, and old exercise-trained hearts (n = 5 per group). Values
indicate Means ± S.E.M. *P < 0.05.
glucose transport (Hall et al., 1994; Rimbaud et al., 2009), fatty
acid oxidation (Rimbaud et al., 2009; Dobrzyn et al., 2013), and
mitochondrial biogenesis (i.e., PGC-1α and Cox4il; Rinaldi et al.,
2013; Wadley et al., 2016). The results of our study (further
decreases in gene expression with exercise training compared
to sedentary aging) compared to these previous studies suggest
that gene expression changes due to exercise training may be
different in the hearts of aged exercise-trained rats compared
to young hearts. Future works looking at post-translational
modifications and protein activity in genes associated with
fatty acid oxidation and mitochondrial function may elucidate
molecular mechanisms involved in potential differential exercise
training responses between young and old rat hearts.
Another limitation to this study is that our primary
endpoint measure was the expression of genes associated with
metabolic signaling pathways, substrate energy metabolism and
mitochondrial function. Along with our data, previous reports
have indicated that changes in tissue mRNA levels are not
necessarily predictive of changes in protein levels (Hall et al.,
1994; Zhu et al., 2013; Lai et al., 2014). Interestingly, other
studies have reported that roughly two-thirds of the variance
in protein content may be explained by mRNA concentration
(Lu et al., 2007; Shankavaram et al., 2007). However, due
to an increasing appreciation of miRNA interactions, post-
translational modifications effecting protein activity, and the
unpredictable protein response to stimuli (i.e., exercise training),
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mRNA is not always a good predictor of protein abundance
(Burelle et al., 2004; Lu et al., 2007; Shankavaram et al.,
2007). Future studies looking at expression changes in cardiac
metabolic and mitochondrial genes, may need to include miRNA
expression changes and post-translational protein modifications
which will provide a more thorough understanding of metabolic
and mitochondrial function in the aged and exercise trained rat
heart.
CONCLUSION
This study was the first to utilize a comprehensive approach in
the study of age and exercise effects in aged hearts on substrate
metabolism andmitochondrial function by an integration of gene
expression, protein content, and protein activity. We found that
cardiac aging results in the downregulation of a large number
of genes associated with fatty acid metabolism, AMPK signaling
and mitochondrial function, and exercise in aged-rats did not
attenuate these changes and resulted in a further downregulation
of expression in many metabolic and mitochondrial genes
compared to aged sedentary rat hearts. We also found that
gene expression changes may or may not coincide with protein
expression. Taken together, our results demonstrated extensive
age-related molecular changes in fatty acid metabolism, AMPK
signaling and mitochondrial function. These molecular changes
are far-reaching and cannot be described by changes in a single
gene or a given gene’s protein product.
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